Financial results are hereby submitted
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
On the reaction day the stock moved 0.9 pts less than Nifty Microcap 250 and 0.1 pts less than its Commodity Chemicals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.
Minute windows have no benchmark: there is no intraday index history to compare against.
HOCL reported a dramatic turnaround in FY25, swinging to a standalone net profit of Rs. 39,154 lakhs from a loss of Rs. (5,531) lakhs in FY24. However, this profit is almost entirely driven by a one-time exceptional gain of Rs. 50,275 lakhs from the Government of India waiving long-standing loans (Rs. 43,586 lakhs), preference shares (Rs. 27,000 lakhs) and accrued interest (Rs. 47,360 lakhs). Core operations remain weak, with revenue from operations falling roughly 22% to Rs. 55,862 lakhs (from Rs. 72,058 lakhs) and a loss before exceptional items of Rs. (10,788) lakhs versus Rs. (5,531) lakhs last year. The auditor issued an unmodified opinion but flagged multiple emphasis-of-matter items, including the GOI waiver, non-compliance with board composition rules (no independent directors/woman director), the audit committee not being functional, and the company preparing accounts on a going concern basis given the ongoing government-approved restructuring. Operating cash flow turned positive at Rs. 63,140 lakhs, boosted by the GOI loan waiver.
The headline profit turnaround is non-recurring and masks continued weakness in core business, with revenue declining sharply. Shareholders should view this as a balance-sheet repair event rather than an operational recovery; the stock is likely to react neutrally or negatively as the underlying operational losses persist and governance issues (non-functional audit committee, board composition non-compliance) remain unresolved.